Philip T. Ninan, MD, is a member of the Editorial Advisory Board of Psychopharmacology Bulletin. Dr. Ninan is an Affiliate Professor of Psychiatry and Behavioral Medicine at the Brody School of Medicine, East Carolina University, and provides consultation to the biopharmaceutical industry. He serves on the national board of the American Foundation forSuicide Prevention.
Previously, he was a Professor of Psychiatry and Behavioral Sciences and Director of the Mood and Anxiety Disorders Program at Emory University School of Medicine in Atlanta, Georgia. From 2006 to 2012 he was a Vice President in Neuroscience, initially at Wyeth Pharmaceuticals (Global Medical Affairs) and subsequently at Pfizer (Clinical Sciences).
Dr. Ninan is certified by the American Board of Psychiatry and Neurology and is a distinguished life fellow of the American Psychiatric Association. In 2003, he received the Psychiatrist of the Year award from the Georgia Psychiatric Physicians Association. He has authored over a hundred peer reviewed journal articles in anxiety and mood disorders, and schizophrenia. His work has been published in medical and scientific journals including Science, New England Journal of Medicine, Proceedings of the National Academy of Sciences, American Journal of Psychiatry, and the Archives General Psychiatry. He has chaired the Treatment Assessment Review Committee of the National Institute of Mental Health, and served on the Scientific Advisory Board for the Anxiety Disorders Association of America.
Dr. Ninan received his medical degree from Christian Medical College, Vellore, India and served an internship at Christian Medical College Hospital, Vellore, India. He immigrated to the U.S. and completed his postdoctoral training in psychiatry at the Medical University of South Carolina, Charleston. He was a medical staff fellow at the National Institute of Mental Health in Bethesda, MD.